Johnson & Johnson (NYSE:JNJ) is appealing a $20 million verdict in a 2018 Indiana pelvic mesh trial, but a federal appeals court panel pushed back against the device maker’s argument this week, according to a published report. J&J’s Ethicon subsidiary claims it was wrongly barred from presenting evidence from the FDA saying that its Prolift pelvic […]
Owlstone, Actelion ink collab pulmonary hypertension breath test dev deal
Owlstone Medical said today that it inked a strategic collaborative deal with Johnson & Johnson‘s (NYSE:JNJ) Actelion to discover and validate a breath-based test intended for the early diagnosis of pulmonary hypertension and its subtypes. Cambridge, UK-based Owlstone Medical said that the collaborative development program will be funded solely by Actelion, and that it will initially […]
J&J’s Auris touts prelim data from first-in-human study of Monarch platform
Johnson & Johnson‘s (NYSE:JNJ) subsidiary Auris Health today released preliminary results from a first-in-human feasibility study of its Monarch robotic interventional platform, which has FDA clearance for diagnostic and therapeutic bronchoscopic procedures. Preliminary data from the Benefit study of the Monarch platform was presented by Dr. Alexander Chen at the American Thoracic Society’s 2019 conference […]
Report: Healthcare CEO pay balloons to $2.6B, quality of care not a factor in bonuses
Healthcare chief execs at 177 top companies collectively saw their compensation grow to $2.6 billion last year while quality of care and improvements to healthcare spending remained at most a marginal factor to their pay, according to an Axios analysis. Despite a focus on pharmaceutical CEOs, medical device company chief execs were five of the […]
FDA labels Ethicon stapler recall as Class I
The FDA today labeled a select recall of Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon’s Endo-Surgery endoscopic and non-endoscopic curved intraluminal staplers with adjustable height staples as Class I. Class I designations, the FDA’s most severe, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The affected staplers […]
HRS 2019 Roundup: Medtronic touts extravascular ICD pilot
The pilot study of an extravascular implantable cardiac defibrillator developed by Medtronic (NYSE:MDT), which is designed to deliver both defibrillation and anti-tachycardia pacing using leads placed outside the heart and venous system, showed strong safety and efficacy results. The safety outcome for the 26-patient study, presented last week at the annual meeting of the Heart […]
J&J’s Ethicon buys Takeda’s TachoSil fibrin patch for $400m
Takeda Pharmaceutical (TSE:4502;NYSE:TAK) said yesterday that it’s dealing its TachSil fibrin patch to Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon for $400 million in cash. The Japanese company, which is still digesting last year’s $62 billion acquisition of Shire, said it also agreed to sell its Xiidra lifitegrast ophthalmic solution to Novartis (NYSE:NVS) for $3.4 billion, […]
Report: Johnson & Johnson to settle metal-on-metal hip cases for $1B
Most of the remaining metal-on-metal hip cases facing Johnson & Johnson (NYSE:JNJ) subsidiary DePuy could reportedly be settled for about $1 billion. The deal, which includes a prior $400 million settlement, covers about 95% of the 6,000 cases involving Pinnacle hip implants that had to be removed, Bloomberg reported, citing two “people with knowledge of […]
J&J’s Ethicon issues urgent field safety notice over intraluminal staplers
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon has released an urgent field safety notice recalling select Intraluminal Staplers distributed in the UK and Ireland over issues with the devices that may affect their performance during surgeries. Ethicon said that after investigating complaints and returned products, it confirmed the occurrence of uncut washers and malformed staples within the recalled […]
Plaintiff wins $120m in latest pelvic mesh trial against Johnson & Johnson unit
A state court jury in Philadelphia reportedly slapped Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon with a $120 million verdict yesterday in a product liability lawsuit brought over one of its pelvic mesh products. The jury in the Pennsylvania Court of Common pleas awarded Susan McFarland $20 million in compensatory damages and $100 million in punitive damages after […]
Johnson & Johnson settles Washington AG’s pelvic mesh suit for $10m
Johnson & Johnson (NYSE:JNJ) has agreed to pay $9.9 million to settle a suit it faced from Washington Attorney General Bob Ferguson over a failure to include serious risks in instructions and marketing materials for surgical mesh devices, according to a Washington State Office of the Attorney General release. Approximately 14,000 women in Washington State have […]
- 1
- 2
- 3
- …
- 109
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube